Retractable Technologies Inc (RVP) - Total Assets
Based on the latest financial reports, Retractable Technologies Inc (RVP) holds total assets worth $142.63 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Retractable Technologies Inc shareholders equity for net asset value and shareholders' equity analysis.
Retractable Technologies Inc - Total Assets Trend (2000–2025)
This chart illustrates how Retractable Technologies Inc's total assets have evolved over time, based on quarterly financial data.
Retractable Technologies Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Retractable Technologies Inc's total assets of $142.63 Million consist of 44.2% current assets and 55.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.59 Million | 1.8% |
| Accounts Receivable | $8.21 Million | 5.8% |
| Inventory | $17.19 Million | 12.1% |
| Property, Plant & Equipment | $79.49 Million | 55.7% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how Retractable Technologies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Retractable Technologies Inc.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Retractable Technologies Inc's current assets represent 44.2% of total assets in 2025, an increase from 39.3% in 2000.
- Cash Position: Cash and equivalents constituted 1.8% of total assets in 2025, down from 18.2% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2000.
- Asset Diversification: The largest asset category is property, plant & equipment at 55.7% of total assets.
Retractable Technologies Inc Competitors by Total Assets
Key competitors of Retractable Technologies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pulse Biosciences Inc
NASDAQ:PLSE
|
USA | $81.62 Million |
|
Caina Technology Co. Ltd.
SHE:301122
|
China | CN¥2.24 Billion |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410
|
China | CN¥2.06 Billion |
|
Guangzhou Jet Bio-Filtration Co Ltd
SHG:688026
|
China | CN¥1.75 Billion |
|
Safe Orthopaedics SA
PA:ALSAF
|
France | €7.94 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
SDI Ltd
AU:SDI
|
Australia | AU$135.84 Million |
Retractable Technologies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.57 | 8.34 | 2.47 |
| Quick Ratio | 4.78 | 6.16 | 2.22 |
| Cash Ratio | 0.27 | 0.48 | 0.00 |
| Working Capital | $53.49 Million | $64.49 Million | $52.79 Million |
Retractable Technologies Inc - Advanced Valuation Insights
This section examines the relationship between Retractable Technologies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.26 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | -11.3% |
| Total Assets | $142.63 Million |
| Market Capitalization | $20.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Retractable Technologies Inc's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Retractable Technologies Inc's assets decreased by 11.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Retractable Technologies Inc (2000–2025)
The table below shows the annual total assets of Retractable Technologies Inc from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $142.63 Million | -11.26% |
| 2024-12-31 | $160.72 Million | -10.55% |
| 2023-12-31 | $179.67 Million | -14.74% |
| 2022-12-31 | $210.74 Million | -1.13% |
| 2021-12-31 | $213.15 Million | +103.06% |
| 2020-12-31 | $104.97 Million | +129.02% |
| 2019-12-31 | $45.84 Million | +24.58% |
| 2018-12-31 | $36.79 Million | -3.57% |
| 2017-12-31 | $38.16 Million | -1.61% |
| 2016-12-31 | $38.78 Million | -8.84% |
| 2015-12-31 | $42.54 Million | -6.20% |
| 2014-12-31 | $45.35 Million | -7.63% |
| 2013-12-31 | $49.10 Million | +3.08% |
| 2012-12-31 | $47.63 Million | -2.32% |
| 2011-12-31 | $48.76 Million | -8.33% |
| 2010-12-31 | $53.19 Million | -1.39% |
| 2009-12-31 | $53.94 Million | -7.85% |
| 2008-12-31 | $58.54 Million | -9.00% |
| 2007-12-31 | $64.33 Million | -9.13% |
| 2006-12-31 | $70.79 Million | -4.01% |
| 2005-12-31 | $73.76 Million | -3.58% |
| 2004-12-31 | $76.49 Million | +223.71% |
| 2003-12-31 | $23.63 Million | +30.85% |
| 2002-12-31 | $18.06 Million | -2.60% |
| 2001-12-31 | $18.54 Million | -9.51% |
| 2000-12-31 | $20.49 Million | -- |
About Retractable Technologies Inc
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allerg… Read more